RNA Canada ARN Education Series | Perspectives on RNA: Nucleic Acid Therapeutics and Delivery
RNA Canada ARN Education Series
Perspectives on RNA: Nucleic Acid Therapeutics and Delivery
Date: Monday, November 17th
Time: 3:00–4:30 PM EST / 12:00–1:30 PM PST
This session will highlight recent advances in RNA-based therapeutics, featuring presentations from leading experts in the field.
Featured Speakers:
• Elisabeth Gardiner, Ph.D. (Chief Scientific Officer, Tevard Biosciences)
The use of therapeutic suppressor tRNAs for the treatment of inherited myopathies (10 min talk)
• Michelle L. Hastings, Ph.D. (Professor, University of Michigan)
Zebronkysen: Advancing a Personalized Antisense Oligonucleotide Therapy for CLN3 Batten Disease from Discovery to the Clinic (10 min talk)
• Omar F. Khan, Ph.D. (Assistant Professor, University of Toronto)
Dark transcriptome medicines and antivirals: unexpected but effective RNA applications (10 min talk)
A ~45-minute panel discussion will follow the presentations.
Register in advance for this meeting:
https://us06web.zoom.us/